期刊文献+

地诺前列酮用于足月妊娠促宫颈成熟及引产的临床效果及安全性分析 被引量:5

Clinical analysis of dinoprostone for cervical ripening and inducing labor in full term pregnancies
下载PDF
导出
摘要 目的探讨地诺前列酮(普贝生)用于足月妊娠促宫颈成熟及引产的效果及安全性。方法采用随机对照前瞻性研究的方法,将90例足月妊娠宫颈Bishop评分3~5分,有引产指征,无前列腺素使用禁忌证的足月单活胎头位孕妇随机分为两组:普贝生组(n=45)患者在阴道后穹窿放置普贝生;缩宫素组(n=45)患者静脉输注缩宫素。结果用药12 h后,普贝生组宫颈成熟度明显优于缩宫素组,平均临产时间、破膜时间、分娩时间均较缩宫素组明显缩短,引产成功率达77.78%,明显高于缩宫素组的33.33%。结论普贝生是一种安全有效的促宫颈成熟和引产药物,值得临床推广。 Objective To investigate the efficacy and safety of dinoprostone for cervical ripening and inducing labor in full term pregnancies. Methods In the prospective, randomized, controlled study, ninety pregnant women with single cephalic term pregnancies ( Bishop score 3~5) were divided randomly into dinoprostone group ( n = 45, treated with dinoprostone) and oxytocin group (n = 45, treated with oxytocin). Results The Bishop score in the dinoprostone group was significantly higher and the parturient time, time of ruptured membranes, labor duration were significantly shorter than those in the oxytocin group at 12 h after treatment. The success rate of labor induction was 77.78% in the dinoprostone group, which was significantly higher than 33. 33% in the oxytocin group. Conclusion Dinoprostone is a safe and effective agent for cervical ripening and inducing labor, and worthy of spreading in clinical practice.
出处 《中国临床新医学》 2011年第5期455-458,共4页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词 地诺前列酮 缩宫素 足月妊娠 宫颈成熟 引产 Dinoprostone Oxytocin Full term pregnancies Cervical ripening Induced labor
  • 相关文献

参考文献7

  • 1Rath W.A clinical evaluation of controlled-release dinoprostone for cervical ripening:a review of current evidence in hospital and outpatient settings[J].J Perinat Med,2005,33(6):491-499.
  • 2吴玲玲,周水生,黄敏.普贝生用于足月妊娠引产116例临床效果[J].广东医学,2008,29(6):1036-1037. 被引量:11
  • 3袁健文,麦玮碧,黎艳.120例足月妊娠引产中普贝生药物的应用及临床分析[J].中国妇幼保健,2009,24(18):2580-2581. 被引量:1
  • 4朱庆双.普贝生用于足月妊娠促宫颈成熟和计划分娩的临床观察[J].中国妇幼保健,2010,25(22):3205-3206. 被引量:2
  • 5Florio P,Lowry PJ,Benedetto C,et al.Maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) levels in post-term pregnancy:effect of prostaglandin administration[J].Eur J Endocrinol,2007,157(3):279-284.
  • 6Nunes FP,Campos AP,Pedroso SR,et al.Intravaginal glyceryl trinitrate and dinoprostone for cervical ripening and induction of labor[J].Am J Obstet Gynecol,2006,194(4):1022-1026.
  • 7Strobelt N,Meregalli V,Ratti M,et al.Randomized study on removable PGE2 vaginal insert versus PGE2 cervical gel for cervical priming and labor induction in low-Bishop-score pregnancy[J].Acta Obstet Gynecol Scand,2006,85(3):302-305.

二级参考文献13

  • 1夏颖丽,郑卫红,王文素,武卉.20年剖宫产率及指征的变迁与围产儿死亡的关系[J].中国优生与遗传杂志,2006,14(12):76-77. 被引量:25
  • 2Raju TN. Historical perspective on the etiology of cerebral palsy [J].Clin perinatol, 2006, 33 (2): 233
  • 3Michael JV, Alexander CA, Joseph KS et al. Increasing prevalence of cerebral palsy among very preterm intants: a population - based study [J] . Pediatrics, 2006, 118 (6) : 1621
  • 4Wing DA, Rahall A, Jones M. Misoprostol: An effective agent for cervical ripening and labor induction [J]. Am J Obstet Gynecology, 1995, 172 (6): 1811.
  • 5曹泽毅.中华妇产科学[M].第2版.北京:人民卫生出版社,2005,1457.
  • 6WITrER F R. Prostaglandin E2 preparation for preinduction cervical ripening clinical[J]. Obstet Gyneeol, 2000, 43(3) : 469 -474.
  • 7MAZOUNI C, PROVENSAL M, MENARD J P, et al. Evaluation of controlled - release dinoprostone Propess for labor induction [J]. Gynecol Obstet Fertil, 2006, 34(6) : 489 -492.
  • 8ROMANELLI M, RIBIANI E, BURNELLI L, et al. Pharmacological induction of labour: benefits and risks [ J ]. Minerva Ginecol, 2007, 59(4) : 347 -355.
  • 9CRANE J M, BENNETT K A. A meta - analysis of controlled - release prostagland for cervical ripening and labour induction[ J ]. J SOGC, 2000, 22(9) : 692 -698.
  • 10于海凤,李秀荣.普贝生用于足月妊娠引产的临床研究[J].中国优生与遗传杂志,2008,16(6):115-115. 被引量:7

共引文献11

同被引文献38

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部